Cargando…

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma

Background: Glioblastoma multiforme (GBM) is the most common malignant tumor in the central nervous system with poor prognosis and unsatisfactory therapeutic efficacy. Considering the high correlation between tumors and angiogenesis, we attempted to construct a more effective model with angiogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Gang, Hu, Jin-Qu, Liu, Ji-Yuan, Zhang, Xiao-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971933/ https://www.ncbi.nlm.nih.gov/pubmed/35372355 http://dx.doi.org/10.3389/fcell.2022.778286

Ejemplares similares

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
por: Balandeh, Ebrahim, et al.
Publicado: (2021)

Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells
por: Musatova, Oxana E., et al.
Publicado: (2023)

Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma
por: Zhao, Liang, et al.
Publicado: (2021)

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme
por: Ye, Yintao, et al.
Publicado: (2023)

Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma
por: Le Joncour, Vadim, et al.
Publicado: (2021)

DNA5mC Regulator-Mediated Molecular Clusters and Tumor Microenvironment Signatures in Glioblastoma
por: Yu, Xinyu, et al.
Publicado: (2022)

Metabolic Drivers of Invasion in Glioblastoma
por: Garcia, Joseph H., et al.
Publicado: (2021)

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells
por: Burster, Timo, et al.
Publicado: (2021)

Research Progress of circRNAs in Glioblastoma
por: Guo, Xu, et al.
Publicado: (2021)

Immunomodulatory effects of extracellular vesicles in glioblastoma
por: Low, Johannes Jun Wei, et al.
Publicado: (2022)

Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway
por: Gao, Yang, et al.
Publicado: (2021)

Therapeutic effect of natural polyphenols against glioblastoma
por: Beylerli, Ozal, et al.
Publicado: (2022)

Roles of STAT3 in the pathogenesis and treatment of glioblastoma
por: Fu, Weijia, et al.
Publicado: (2023)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis
por: Kang, Jiawen, et al.
Publicado: (2023)

A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma
por: Lin, Cha, et al.
Publicado: (2021)

Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors
por: Liu, Qi-Fang, et al.
Publicado: (2021)

Identification of a Glycosyltransferase Signature for Predicting Prognosis and Immune Microenvironment in Neuroblastoma
por: Sha, Yongliang, et al.
Publicado: (2022)

Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells
por: Azzarelli, Roberta
Publicado: (2020)

Ivacaftor Inhibits Glioblastoma Stem Cell Maintenance and Tumor Progression
por: Liu, Kun, et al.
Publicado: (2021)

Unveiling a Ghost Proteome in the Glioblastoma Non-Coding RNAs
por: Cardon, Tristan, et al.
Publicado: (2021)

The dark side of mRNA translation and the translation machinery in glioblastoma
por: Montiel-Dávalos, Angélica, et al.
Publicado: (2023)

Pentraxin 3 Promotes Glioblastoma Progression by Negative Regulating Cells Autophagy
por: Wang, Zeyu, et al.
Publicado: (2020)

SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
por: Kumari, Smita, et al.
Publicado: (2023)

The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme
por: Wang, Liang, et al.
Publicado: (2022)

Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies
por: Liu, Zaoqu, et al.
Publicado: (2022)

Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma
por: Zhang, Yulian, et al.
Publicado: (2022)

The Pyroptosis-Related Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Gastric Cancer
por: Shao, Wei, et al.
Publicado: (2021)

Association of Angiogenesis Gene Expression With Cancer Prognosis and Immunotherapy Efficacy
por: Li, Xin-yu, et al.
Publicado: (2022)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma
por: Liu, Kun, et al.
Publicado: (2022)

VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
por: Navarro-Carrasco, Elena, et al.
Publicado: (2021)

Quaking but not parkin is the major tumor suppressor in 6q deleted region in glioblastoma
por: Aksoy Yasar, Fatma Betul, et al.
Publicado: (2022)

Lrig1 regulates the balance between proliferation and quiescence in glioblastoma stem cells
por: Ferguson, Kirsty M., et al.
Publicado: (2022)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Identification of an Metabolic Related Risk Signature Predicts Prognosis in Cervical Cancer and Correlates With Immune Infiltration
por: Shang, Chunliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1lqcjk3guigd35f9cpjhn6ti94